2-((2R)-1-Azabicyclo[2.2.2]oct-2-yl)-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one

ID: ALA4572218

Cas Number: 1330782-69-8

PubChem CID: 136443810

Product Number: M669834, Order Now?

Max Phase: Preclinical

Molecular Formula: C17H19N5OS

Molecular Weight: 341.44

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cc1n[nH]cc1-c1cc2nc([C@H]3CC4CCN3CC4)[nH]c(=O)c2s1

Standard InChI:  InChI=1S/C17H19N5OS/c1-9-11(8-18-21-9)14-7-12-15(24-14)17(23)20-16(19-12)13-6-10-2-4-22(13)5-3-10/h7-8,10,13H,2-6H2,1H3,(H,18,21)(H,19,20,23)/t13-/m1/s1

Standard InChI Key:  XGVXKJKTISMIOW-CYBMUJFWSA-N

Molfile:  

 
     RDKit          2D

 24 28  0  0  0  0  0  0  0  0999 V2000
   19.8928  -12.5674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.6146  -12.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6146  -11.3210    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.8928  -10.9000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1710  -12.1547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1665  -11.3210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3714  -11.0687    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.8906  -11.7448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3787  -12.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0561  -11.7543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5598  -11.0835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7675  -11.3444    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7720  -12.1782    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.5671  -12.4345    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8939  -10.0663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.8281  -13.2227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3294  -12.5719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3270  -13.4024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.0429  -13.8195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7656  -13.4065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7679  -12.5760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0476  -12.1585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0518  -12.6665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1385  -13.2649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  6  4  1  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  8 10  1  0
  4 15  2  0
 14 16  1  0
 17 18  1  0
 17 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 17  2  1  1
 21 23  1  0
 23 24  1  0
 24 18  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4572218

   6-(3-methyl-1H-pyrazol-4-yl)-2-[(2R)-quinuclidin-2-yl]-3H-thieno[3,2-d]pyrimidin-4-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 341.44

Molecular Weight (Monoisotopic): 341.1310

AlogP: 2.84

#Rotatable Bonds: 2

Polar Surface Area: 77.67

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.91

CX Basic pKa: 6.08

CX LogP: 1.53

CX LogD: 1.50

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.75

Np Likeness Score: -1.27

References

1. Kurasawa O, Miyazaki T, Homma M, Oguro Y, Imada T, Uchiyama N, Iwai K, Yamamoto Y, Ohori M, Hara H, Sugimoto H, Iwata K, Skene R, Hoffman I, Ohashi A, Nomura T, Cho N..  (2020)  Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent.,  63  (3): [PMID:31895562] [10.1021/acs.jmedchem.9b01427]

Source

Source(1):

• Scientific Literature